Few studies have explored RAC1's role in the tumor immune microenvironment, although some indicate RAC1 mutations can upregulate the PD-L1 expression in melanoma12 and regulate the function of Th17 cells in autoimmune diseases45. This evidence concerns the gene RAC1 and neoplasm.